Advancing Boron Neutron Capture Therapy to Treat Cancer
We’re developing novel boron medicines that enable BNCT for oncology indications with high unmet clinical need.
An emerging modality with the potential to improve outcomes for patients with a variety of cancers
Boron neutron capture therapy is a precision medicine approach for treating solid tumors that is being advanced to destroy cancerous cells while leaving healthy cells unharmed.
We’re building an ecosystem to advance BNCT
Through partnerships with biopharma companies and academic medical centers, we are working expand access to this promising modality.
Aviko Radiopharmaceuticals and Neutron Therapeutics Form Exclusive, Strategic Partnership with Leo Cancer Care to Expand Development of Boron Neutron Capture Therapy for Treating Cancer
Advances in Boron Neutron Capture Therapy, © IAEA, Vienna (2023)
Aviko Radiopharmaceuticals and Neutron Therapeutics Form Strategic Partnership to Advance Boron Neutron Capture Therapy
If you would like to learn more about partnering to expand access to BNCT, please get in touch.
We partner with chemists, biologists and other biopharma companies to develop next generation BNCT medicines.
We are building partnerships with leading medical centers to provide BNCT care to patients.